Denali Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,251
Closed -$109K 342
2025
Q3
$109K Hold
10,251
0.01% 295
2025
Q2
$99.2K Buy
+10,251
New +$106K 0.01% 287
2024
Q2
Sell
-1,430
Closed -$26.9K 369
2024
Q1
$26.9K Sell
1,430
-5,817
-80% -$99.8K 0.01% 313
2023
Q4
$105K Hold
7,247
0.03% 270
2023
Q3
$126K Buy
7,247
+5,337
+279% +$111K 0.04% 259
2023
Q2
$39.7K Sell
1,910
-713
-27% -$15.5K 0.01% 300
2023
Q1
$61.7K Sell
2,623
-12,083
-82% -$324K 0.03% 204
2022
Q4
$411K Sell
14,706
-2,500
-15% -$63.9K 0.17% 119
2022
Q3
$403K Buy
17,206
+13,325
+343% +$402K 0.19% 114
2022
Q2
$131K Buy
+3,881
New +$136K 0.06% 162

Other funds holding OGN

Denali Advisors's OGN Position: Q4 2025 in Review

Denali Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 10,251 shares — an estimated $109K sold.

Denali Advisors first reported a position in OGN in Q2 2022 and held it in 10 quarters. The position peaked at $411K in Q4 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Denali Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Denali Advisors sold 10,251 Organon & Co shares in Q4 2025, an estimated $109K.
  • Denali Advisors first reported a position in Organon & Co in Q2 2022 and held it in 10 quarters.
  • Denali Advisors's Organon & Co position peaked at $411K in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Denali Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.